Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CytoFab in severe sepsis
NCT00615017Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2008
- Primary completion
- Jul 2009
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of AZD9773 in sepsis, sponsored by AstraZeneca. Started Jan 2008; status: completed.
02
Drugs
AZD9773
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00615017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615017.